Sugi Predict

Sugi Predict / Targets / RBM25

RBM25

RNA-binding protein 25 · P49756 · RBM25 on Sugi Atlas →

0 patent compounds predicted against RBM25, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RBM25 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia PHASE1RECRUITING
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
SRSF2 Gene Mutation in Patients With t-MDS/AML nanCOMPLETED
Longitudinal Study of Neurogenetic Disorders nanRECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN
Modulation of Steroid Immunosuppression by Alveolar Efferocytosis nanCOMPLETED
Predictive Value of Maternal Blood Protein Signatures in Preterm Birth nanCOMPLETED
MYO-SHARE: MYO-MRI in Neuromuscular Diseases nanENROLLING_BY_INVITATION
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Precision Diagnosis and Therapy for Rare Diseases by Interpreting Non-coding Genomes nanRECRUITING
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Transcriptomic Analysis of Fibroblasts and Blood in Patients With Rare Diseases nanRECRUITING
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a RBM25 binder may also engage these)

ProteinNameSimilarity
B2RY56 — 1.000 B2RY56 →
U2SURP U2 snRNP-associated SURP motif-containing protein 0.996 landscape →
Q6NV83 — 0.993 Q6NV83 →
B3MJ69 — 0.992 B3MJ69 →
SMARCC2 SWI/SNF complex subunit SMARCC2 0.991 landscape →
B4H732 — 0.991 B4H732 →
Q5R7X2 — 0.991 Q5R7X2 →
B4II37 — 0.991 B4II37 →
Q9V9K7 — 0.990 Q9V9K7 →
Q28WQ8 — 0.989 Q28WQ8 →
Q7ZYR8 — 0.989 Q7ZYR8 →
Q95XU6 — 0.988 Q95XU6 →
Q8IWZ8 — 0.988 Q8IWZ8 →
Q8CGF7 — 0.988 Q8CGF7 →
B4QCR6 — 0.988 B4QCR6 →
Q4KLS8 — 0.988 Q4KLS8 →
Q641G3 — 0.988 Q641G3 →
A8XEG9 — 0.988 A8XEG9 →
Q5TUF1 — 0.988 Q5TUF1 →
B3N3F7 — 0.988 B3N3F7 →
B3H615 — 0.988 B3H615 →
Q7ZVW9 — 0.987 Q7ZVW9 →
P53709 — 0.987 P53709 →
Q28C44 — 0.987 Q28C44 →
Q6P2W5 — 0.987 Q6P2W5 →
Q7TPW1 — 0.987 Q7TPW1 →
Q05D44 — 0.987 Q05D44 →
Q5ZL35 — 0.987 Q5ZL35 →
Q5XHJ5 — 0.987 Q5XHJ5 →
P19351 — 0.987 P19351 →